Suppr超能文献

[药物相关的智力水平提高。思考与氟桂利嗪(西比灵)的双盲研究(作者译)]

[Drug-related increase of intelligence level. Considerations and a double-blind-study with flunarizin (sibelium) (author's transl)].

作者信息

Lehrl S, Sollberg G, Schumacher H

出版信息

Pharmakopsychiatr Neuropsychopharmakol. 1978 May;11(3):134-46. doi: 10.1055/s-0028-1094572.

Abstract

Fluid and crystallized intelligence are two second-order factors that are differentiated within the intelligence model by R.B.Cattell. Fluid intelligence is considered to be a biological capacity relatively independent of environmental influences. Crystallized intelligence, however, is connected to accultured skills and knowledge. The capacity of fluid intelligence decreases by non-optimal states of general activation, functional psychosis (physically founded reversible psychosis) or defect-syndromes (physically founded irreversible psychosis). Fluid intelligence can increase by drugs only, if the functional psychosis is diminished or if the state of activation is optimized. There is no drug-effect on crystallized intelligence but an indirect influence via fluid intelligence. The hypothesis of the drug-related increase of fluid intelligence as a correlate to the diminuition accompanying the functional psychosis should be confirmed by a clinical experiment. Therefore two samples of 20 patients each with a functional psychosis following cerebral blood-flow disturbances received flunarizine (Sibelium) and placebo respectively during a double-blind study lasting 12 weeks. Under the activ substance to be applied for amelioration of peripheral and central blood-flow the measured values of fluid intelligence increased six weeks after starting therapy, while there were no changes under placebo. In the end of the investigation the measured intellectual capacity had increased by 50 per cent under flunarizine.

摘要

流体智力和晶体智力是R.B.卡特尔智力模型中区分出的两个二阶因素。流体智力被认为是一种相对独立于环境影响的生物能力。然而,晶体智力与文化技能和知识相关。流体智力的能力会因一般激活的非最佳状态、功能性精神病(基于身体原因的可逆性精神病)或缺陷综合征(基于身体原因的不可逆性精神病)而下降。只有当功能性精神病减轻或激活状态得到优化时,流体智力才能通过药物提高。药物对晶体智力没有影响,但会通过流体智力产生间接影响。与功能性精神病减轻相关的药物导致流体智力增加的假设应该通过一项临床实验来证实。因此,在一项为期12周的双盲研究中,两组各20名因脑血流紊乱而患有功能性精神病的患者样本分别接受了氟桂利嗪(西比灵)和安慰剂治疗。在应用用于改善外周和中枢血流的活性物质后,流体智力的测量值在治疗开始六周后增加,而在安慰剂组则没有变化。在研究结束时,接受氟桂利嗪治疗的患者的智力测量能力提高了50%。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验